Study to track pancreatic cancer treatment choices
Part of Cancer clinical trials.
This study looks at people with non-metastatic, difficult-to-operate pancreatic cancer to better understand how treatment is selected and adjusted at different stages. It may help by testing a “dynamic” approach to assessment over time, before and alongside planned treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic adenocarcinoma that has not spread to distant sites (not metastatic)
- Your tumor is not immediately removable by surgery (borderline or locally advanced)
- You have not had prior surgery or chemotherapy for this cancer
- You are over 18 and able to take part in treatment (good enough general health for care or surgery)
- You plan to receive treatment at the Paoli-Calmettes Institute and can sign this specific study consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at genetic material and proteins from pancreatic tumors to understand how the cancer responds to treatment. It aims to help doctors choose the best therapies for patients with certain types of pancreatic cancer that can be removed surgically or that have not spread to other organs.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
This trial looks at a patient’s “metabolic profile” (how the body’s chemicals are used) in people with certain liver and pancreatic tumors. It may help doctors better understand these cancers and improve how they are evaluated for treatment.
This study looks at how the metabolism of pancreatic cancer cells affects their surroundings. It uses a biopsy (removing a small sample of tissue from a tumor in the pancreas, liver, or lung) to learn more about the cancer and guide treatment.
This study looks at blood samples from people with newly diagnosed pancreatic cancer to understand how the immune system responds. It may help find better ways to treat the disease in the future.
This study collects medical and lab information from adults with pancreatic cancer to help researchers understand care and outcomes. You may be asked for follow-up visits and basic data, and it may be used to improve future treatments.
Hear when a new Pancreatic Cancer Non-resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.